Analyst Research

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: S&P Capital IQ Factual Report
$127.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Arrhythmia Research Technology Inc Issues Q1 2013 Guidance; Announces Delay In Finalizing First Quarter Of 2013 Results


Friday, 17 May 2013 09:01am EDT 

Arrhythmia Research Technology Inc announced first quarter of 2013, it expects consolidated revenues of $5,640,000 and net income of $4,000. The Board also announced that it will not be able to file its quarterly report on Form 10-Q for the interim period ended March 31, 2013 within the automatic extension of its due date to May 20, 2013 afforded by its filing of a Form 12b-25 Notification of Late Filing with the Securities and Exchange Commission. 

Company Quote

6.9
0.01 +0.15%
15 Sep 2014